baber/WOPTO huggingface dataset:
Patent NZ-577290-A (NZ)
Title: Making a winding for a slotless stator by collapsing coil groups into a single layer web with interleaving coil segments
Inventor: SUZUKI HIROSHI
IPC: H02K15/04
Filed: 2007-12-26
Abstract: A method for making a three-phase field winding for a slotless stator including a plurality of coil windings arranged in a first coil group and a second coil group, and a three-phase field winding is disclosed. The method comprises the steps of: forming the first coil group; after forming the first coil group, axially shifting along the mandrel the insulated wire; forming the second coil group; removing the mandrel; and collapsing the wound first coil group and the second coil group to a single layer web. The first coil group is formed by winding an insulated wire for each coil winding around a mandrel such that each turn of the wire is adjacent a next turn of the wire. Each coil winding in the first coil group has substantially the same coil width when completed. The separation between adjacent coil windings in the first coil group is a distance substantially equal to the width of one of the completed windings. After forming the first coil group, the insulated wire is axially shifted along the mandrel from a trailing edge of each coil winding a distance substantially equal to five times the width of one of the completed windings, to position the wires at a leading edge of each of coil winding in the second coil group. The second coil group is formed by winding the insulated wire for each coil winding around the mandrel such that each turn of the wire is adjacent a next turn of the wire. Each coil winding in the second coil group and the first coil group has substantially the same coil width when completed. The separation between adjacent coil windings in the second coil group is a distance substantially equal to the width of one of the completed windings. Upon removing the mandrel from the wound first and second coil groups, the first coil group and the second coil group is collapsed to a single layer web such that one or more coil winding segments from the first coil group interleave between coil winding segments of the second coil group, whereby wrapping the single layer web into a cylinder forms the field winding.
Patent NZ-578511-A (NZ)
Title: Training system
Inventor: MARTIN GLENN NEIL
IPC: G05B13/00
Filed: 2009-07-20
Abstract: A training system for the solo operation of a powered vehicle is disclosed. The training system includes a) providing means for electronic control of the speed and orientation of a ground vehicle or of the speed, orientation and height of a flying vehicle; b) providing a virtual enclosure training area delineated by a plurality of spaced sensors and c) providing means associated with the vehicle for communicating with, and receiving instructions from, each of the sensors. The instructions received from the sensors may be used to control the means for electronic control such that movement of the vehicle is restricted to the virtual enclosure training area, and within the virtual enclosure training area, the speed and orientation of a ground vehicle or the speed, orientation and height of a flying vehicle controlled within preset parameters.
Patent NZ-580338-A (NZ)
Title: Cereal-based infant nutrition with fibre
Inventor: STAHL BERND
IPC: A23L33/00
Filed: 2008-03-21
Abstract: Provided is a nutritional composition with a viscosity between 150 and 100,000 mPas at 20 degrees Celsius and at a shear rate of 10 s-1, comprising: 10 to 99 wt.% cereal component based on dry weight of the nutritional composition; 1.0 to 30 wt.% fibre based on dry weight of the nutritional composition; 0.5 to 95 wt. % uronic acid carbohydrate with a degree of polymerisation of 10 to 300 based on total fibre; and comprising 5 to 95 wt.% soluble, non-digestible carbohydrates based on total fibre, wherein the soluble, non-digestible carbohydrate is selected from the group consisting of galactose- oligo- and/or polysaccharide (including transgalactooligo- and/or polysaccharides), xylooligo- and/or polysaccharide, gluco-oligo and/or polysaccharide (including gentio-oligosaccharides, malto-oligosaccharides, isomalto-oligosaccharides, resistant dextrins and cyclodextrins, arabinooligosaccharide, mannan-oligosaccharide, galactomanno-oligo- and/or polysaccharides, glucomanno-oligo- and/or polysaccharides, arabinogalactooligo- and/or polysaccharides, fructo-oligosaccharides, and fructopolysaccharides. The compositions can be used as nutrition to babies during transition from baby food to adult food and reducing post-prandial glucose level in blood.
Patent NZ-581800-A (NZ)
Title: Vanadium-drier intaglio ink
Inventor: LEFEBVRE OLIVIER
IPC: C09D11/02
Filed: 2008-07-02
Abstract: Disclosed is an oxidatively curing printing ink comprising a. at least one oxidatively curable material; b. at least one anionic macromolecular surfactant; c. at least one wax component; d. pigment and/or filler wherein the ink furthermore comprises a salt of vanadium.
Patent NZ-583873-A (NZ)
Title: A wrapping film with two ply reinforced edges
Inventor: JAGER NORBERT
IPC: B29C55/00
Filed: 2008-10-08
Abstract: Disclosed is a device and method for producing a stretch film with at least one adhesive side and with reinforced edges to provide increased and durability. The method for producing a film with reinforced edges and/or borders includes the steps of during the process of producing said film, before it is rolled up for the first time, a strip of the same film or a further film is respectively applied to the borders of the film in such a way that the film is at least double-ply at least in the region of the edges. The strips are applied in such a way that the strips terminate almost flush as far as possible with the edges of the film. The strips of the further film have an adhesive side and a non-adhesive side and the adhesive side comes into contact with the film to be protected. The strips are applied on the upper side and/or underside of the film. The strips are cut off at the borders of the film immediately after the casting or extrusion of the film and the strips are turned over and brought into contact again with the film before the film is rolled up for the first time.
Patent NZ-584785-A (NZ)
Title: Method of preparing (6r)-3-hexyl-4-hydroxy-6-undecyl-5,6-dihydropyran-2-one, and intermediate used in the method
Inventor: YUN SANG MIN
IPC: C07D309/36
Filed: 2008-10-29
Abstract: Disclosed is a method for preparing (6R)-3-hexyl-4-hydroxy-6-undecyl-5,6-dihydropyran-2-one of formula (I) which comprises; reacting a compound of formula (II) with a compound of formula (III) in the presence of zinc to form a compound of formula (IV). The compound of formula (IV) is then treated with an aqueous acid to obtain a compound of formula (V), which is then cyclised under an acidic or basic condition. Also disclosed is a (5R)-2-hexyl-5-hydroxy-3-iminohexadecanoate derivative of formula (IV).
Patent NZ-592442-A (NZ)
Title: A generator with adjustment for the concentricity and shape of the stator support around the rotor support
Inventor: GELMINI EMMANUELE
IPC: F16C41/02
Filed: 2011-04-21
Abstract: A wind power turbine (1) for producing electric energy is disclosed with adjustment of the air gap between a rotor and a stator. The wind turbine (1) comprising a vertical structure, a nacelle on top of the vertical structure; a blade assembly fitted in rotary manner to the nacelle; and an electric generator. The generator has a tubular first supporting structure (12) extending about an axis of rotation (A1) and partly defining the nacelle. A second supporting structure also extending about the axis of rotation (A1) is substantially coaxial with the first supporting structure, and fitted to the first supporting structure to rotate about the axis of rotation. An annular gap is defined between active parts attached to the support structures. At radial tensioning device (23) for adjusting the shape of the first supporting structure about the axis of rotation (A1) is fitted to the first supporting structure. More specifically, radial tensioning device (23) comprises an annular plate (24) and a number of radial arms (25) extending from an annular plate (24) to supporting structure (12), and equally spaced about axis of rotation (A1). Each radial arm (25) is connected to annular plate (24) to slide radially with respect to axis of rotation (A1) and is fixable to annular plate (24). Radial tensioning device (23) also has a number of adjusting mechanisms (26), each associated with a respective radial arm (25) to slide the associated radial arm (25) radially with respect to annular plate (24) thus adjusting the shape of the first supporting structure about the axis of rotation (A1).
Patent NZ-592705-A (NZ)
Title: 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
Inventor: PHADKE AVINASH
IPC: C07D245/04
Filed: 2009-12-10
Abstract: 592705 The disclosure provides 4-amino-4-oxobutanoyl peptides and cyclic analogues thereof of Formula I and the pharmaceutically salts thereof. The variables are defined herein. Certain compounds of Formula I are useful as antiviral agents. 4-amino-4-oxobutanoyl peptide cyclic analogues as disclosed herein are potent and/ or selective inhibitors of viral replication, particularly Hepatitis C virus replication. The disclosure also provides pharmaceutical compositions containing one or more 4-amino-4-oxobutanoyl peptide cyclic analogues and one or more pharmaceutically acceptable carriers. Such pharmaceutical compositions may contain a 4-amino-4-oxobutanoyl peptide cyclic analogue as the only active agent or may contain a combination of a 4-amino-4-oxobutanoyl peptide cyclic analogue and one or more other pharmaceutically active agents. The disclosure also provides methods for treating viral infections, including Hepatitis C infections, in patients.
Patent NZ-592971-A (NZ)
Title: Solid dosage forms of bendamustine
Inventor: PATZAK ULRICH
IPC: A61K33/243
Filed: 2009-12-03
Abstract: 592971 Disclosed is a pharmaceutical composition in a solid dosage form for oral administration, the composition comprising bendamustine or a pharmaceutically acceptable ester, salt or solvate thereof as an active ingredient, and at least one pharmaceutically acceptable excipient, which is a pharmaceutically acceptable saccharide selected from the group consisting of one or more of a monosaccharide, a disaccharide, an oligosaccharide, a cyclic oligosaccharide, a polysaccharide and a saccharide alcohol, wherein the ratio by weight of the active ingredient to the saccharide excipient(s) is in the range of 1:1-10, and wherein the pharmaceutical composition is in the form of a tablet, a granulate, or a pill. Also disclosed is the use of the composition in the manufacture of a medicament for the treatment of a medical condition which is selected from chronic lymphocytic leukemia, acute lymphocytic leukaemia, chronic myelocytic leukaemia acute myelocytic leukaemia, Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, breast cancer, ovary cancer, small cell lung cancer, non-small cell lung cancer, and an autoimmune disease.
Patent NZ-593142-A (NZ)
Title: Purification of methyl methacrylate using sulphonic acid ion exchange resin
Inventor: JOHNSON DAVID WILLIAM
IPC: C07C67/60
Filed: 2009-12-11
Abstract: ABSTRACT - 593142 The disclosure relates to a process for purifying methyl methacrylate (MMA) comprising contacting liquid MMA having impurities therein with a sulphonic acid resin, in the presence of formaldehyde or a suitable source of methylene or ethylene of formula (I) as defined herein, where R5 and R6 are independently selected from C1-C12 hydrocarbons or H; X is O; n is an integer from 1 to 100; and m is 1 or 2, wherein the impurities are selected from isobutyraldehyde, either as isobutyraldehyde or in a compound which regenerates isobutyraldehyde when exposed to the sulphonic acid ion exchange resin, optionally substituted C6-C20 trienes, optionally substituted unsaturated aldehydes and ketones, divinyl ketone, ethyl vinyl ketone, diethyl ketone, ethyl isopropenyl ketone, 3-methylene 1-hexen-4-one, methacrolein, isobutanol, toluene, and pentenals (preferably the impurities comprise 3-pentenal).
Patent NZ-593308-A (NZ)
Title: Device for topically dispensing a powder including a gasflow generator to agitate an attached powder receptacle
Inventor: GREENHALGH PAUL
IPC: A61M11/00
Filed: 2009-12-15
Abstract: 593308 Disclosed is a device (20) for the topical dispensing of a powder, typically a powder medicament, comprises, or is adapted to be coupled to, a powder receptacle (31) and a gas flow generator. The gas flow generator is adapted, in use, to cause gas to flow through the device (20), which further comprises an agitator by which the powder and/or the powder receptacle (31) can be mechanically agitated. Actuation of the gas flow generator, which causes gas to flow through the device (20) and to entrain powder from the powder receptacle (31), thereby to dispense powder from the device (20), is accompanied by actuation of the agitator, causing the powder receptacle (31) to be mechanically agitated, thereby facilitating the release of powder from the powder receptacle (31).
Patent NZ-596144-A (NZ)
Title: Indole derivatives and methods for antiviral treatment
Inventor: HUANG SONG XIAO
IPC: C07D409/14
Filed: 2010-04-05
Abstract: 596144 Disclosed herein is a compound of formula (I), wherein the variables are defined in the specification, or a free acid, free base, salt, hydrate, solvate, clathrate, isotopologue, racemate, enantiomer, diastereomer, stereoisomer or polymorph form thereof; and the use of said compound in the treatment of a viral infection, wherein the viral infection is hepatitis C virus. Embodiments of the compound include the following: N-[6-(3-cyano-1-cyclobutyl-6-methoxy-1H-indol-2-yl)pyridazin-3-yl]ethanesulfonamide, and 5-fluoro-6-methyl-1-(pyridin-3-yl)-2-(5-{ [(2S)-1,1,1-trifluoropropan-2-yl]sulfamoyl} pyridin-2-yl)-1H-indole-3-carboxamide.
Patent NZ-598458-A (NZ)
Title: Hybrid polypeptides including meningococcal fhbp sequences
Inventor: RAPPUOLI RINO
IPC: A61K39/095
Filed: 2010-08-27
Abstract: NZ 598458 Disclosed is a polypeptide comprising a first immunogenic amino acid sequence and a second immunogenic amino acid sequence, wherein the first immunogenic amino acid sequence comprises an amino acid sequence set forth in SEQ ID NO: 23 as defined in the complete specification. Also disclosed is the use of said polypeptide in the preparation of a medicament for the treatment or prevention of infection by Neisseria meningitides.
Patent NZ-602038-A (NZ)
Title: Void former and method of reinforcing
Inventor: DUNLOP RONALD LINDSAY
IPC: E04G15/04
Filed: 2012-08-24
Abstract: Disclosed is a void former for forming a void in a concrete element for receiving at least one flexible or pliant reinforcing member such as a steel wire cable. The void former is arc or U shaped or configured so that the void formed by said void former comprises an aperture in a surface of the concrete element for a said pliant reinforcing member to at least enter the void, and an internal surface shaped to direct the pliant reinforcing member through the void and back towards the surface of the concrete element to exit the void at the surface of the concrete element at a distance away from a portion of the pliant reinforcing member entering the void. The void former can have an entrance and an exit aperture in the surface of the concrete with a tube-like conduit extending between the entrance aperture and the exit aperture.
Patent NZ-603853-A (NZ)
Title: Manipulation of organic acid biosynthesis and secretion (7)
Inventor: SPANGENBERG GERMAN
IPC: A01H5/00
Filed: 2004-04-14
Abstract: 603853 Disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment encoding citrate synthase (CS), or complementary or antisense to a sequence encoding CS, and including a nucleotide sequence selected from the group consisting of (a) sequences shown in Figures 102 and 104 hereto (SEQ ID NOS 336 and 338 to 344, respectively); (b) complements of the sequences recited in (a); (c) sequences antisense to the sequences recited in (a) and (b); (d) functionally active fragments and variants having at least approximately 95% identity to the functional part of the sequences recited in (a), (b) and (c) and having a size of at least 60 nucleotides; and (e) RNA sequences corresponding to the sequences recited in (a), (b), (c) and (d). Further disclosed is a substantially purified or isolated CS polypeptide including an amino acid sequence selected from the group consisting of sequences shown in Figure 103 hereto (SEQ ID NO 337); and functionally active variants thereof having at least approximately 90% identity to the recited sequences. SEQ ID NO: 337MSTTTTTTDESKLHDAARNRLATLSAHLLPSSTTSAALLHPIHLSSSSGISPPSNVKGTLTVVDERTGKKYTIEVSPDGTVKANDFKKISTGKNDKGLKLYDPGYLNTAPVRSTISYIDGDEGILRYRGYPIEELAEKSTFPEVAYLILYGNLPSANQLQEWEFAISQHSALPQGVLDLIQSMPQDAHPMGVLVNAISALSVFHPDANPALRGLDIYNSKQVRDKQIARIIGKITTIAAAINLRMAGRPPVLPSNKLSYTENFLYMLDSLGNRSYKPNPQLTRALDIIFILHAEHEMNCSTSAVRHLASSGVDVYTAIAGGVGALYGPLHGGANEAVLKMLSEIGSVDNIPEFIEGVX
Patent NZ-615607-A (NZ)
Title: Radiation treatment brassiere
Inventor: THOMPSON ELIZABETH CHABNER
IPC: A41C3/00
Filed: 2012-02-15
Abstract: A bra to accommodate and position a woman’s breasts when receiving radiation treatment to ensure precise and reproducible radiation is delivered to a target area during each treatment session includes two breast cups (102A, 102B); a medial window (108); two shoulder straps (104A, 104B) and a back band. The medial window (108) is visually transparent and is disposed between the two breast cups (102A, 102B). The two shoulder straps (104A, 104B) support the two breast cups (102A, 102B). The back band couples the shoulder straps (104A, 104B) and the two breast cups (102A, 102B). The breast cups (102A, 102B), medial window (108), shoulder straps (104A, 104B) and back band, by virtue of the materials of construction, do not scatter or substantially attenuate treatment radiation. The bra is configured so that when worn, no portion of a vertical midline of a wearer’s chest is obscured by the bra so that a light field can be projected through the medial window (108) onto a wearer’s chest and viewed without obstruction.
Patent NZ-627988-A (NZ)
Title: Gear assembly and use in cylinder lock
Inventor: NAROVLANSKY BORIS
IPC: G07C9/00
Filed: 2013-02-06
Abstract: A reduction gear assembly (10) suitable for use in a cylinder lock is described. The assembly offers a significant decrease in size from known reduction gears due to its configuration. The assembly is also axial, in that the input and output rotations are on the same axis. Reduction of cog speed is reduced by way of an outer gear (14) encompassing an inner gear (12) with a decreased radius such that they are in contact but are not fully interlocking. Rotation of a first shaft (22) with an elliptical or eccentric portion (24) causes the inner gear (12) to revolve or orbit, thus rotating the outer gear (14) and its shaft (20) at a slower rate. Optionally, the reduction gear can include limiters (26, 30) that decrease the efficiency of the translational movement, a counterweight (36) for balance of the eccentric portion, and can be reversed such that the outer gear provides the elliptical or translational movement (Figure 4).
Patent NZ-707340-A (NZ)
Title: Protective screen and visor produced therewith for a safety helmet, particularly a forestry worker’s helmet
Inventor: GREBER MARTIN
IPC: A42B3/22
Filed: 2013-10-16
Abstract: A protective screen (10) to protect the face and, above all, the eyes of a person against flying particles and sharp objects has a mesh (12) with a mesh structure which is formed from a plurality of adjacent rows of hexagonal openings (14), which rows are bounded by mesh webs (16) common to the openings (14). The openings (14) in the mesh (12) are each of substantially the same area. The mesh (12) is enclosed by an edge (18) with no mesh structure which has a width (B) which is at least equal to the height (H) of a row of openings (14) in the mesh structure. The mesh webs (16) of at least two rows of openings (14) adjacent to the edge (18) can be made thicker than the mesh webs for the other openings, wherein, however, all the openings in the mesh (12) are nevertheless substantially identical in area. The mesh (12) is produced by etching spring steel sheet. A visor for a safety helmet, especially a forestry worker’s helmet is produced from the protective screen (10) by injection moulding a supporting frame around its edge (18).
Patent NZ-708552-A (NZ)
Title: Brim of an insulated container
Inventor: LESER CHRIS K
IPC: B65D81/38
Filed: 2013-12-13
Abstract: The present disclosure relates to vessels, and particular to insulated containers, such as cups, for containing hot or cold beverages or food, prone to spilling when the insulated container includes a brim allowing a leak path. More particularly, the present disclosure relates to an insulated cup formed from polymeric materials. A container is formed to include an interior region and a polymeric rolled brim defining a mouth opening into the interior region. The container includes a floor and a side wall coupled to the floor and to the brim. The brim includes a substantially smooth brim seam, being defined by a first material segment having a first density and a second material segment having a second density and an inner rolled tab of the brim seam being defined by a second material segment having a lower second density, between the first and second ends of the brim lips, with the substantial smoothness of the brim preventing a leak path.